Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MET-Rx is a pioneer in the sports nutrition industry, specializing in high-protein meal replacements and performance supplements. Founded in 1991 by anesthesiologist Dr. A. Scott Connelly, the brand was initially developed to prevent muscle wasting in critically ill patients before becoming a staple in the bodybuilding and athletic communities. The company is best known for its proprietary Metamyosyn protein blend, a combination of milk protein isolate, casein, and whey protein designed for prolonged amino acid release. Its product portfolio includes the popular Big 100 Colossal meal replacement bars, protein powders, and ready-to-drink shakes. Currently a brand under the Nestlé Health Science umbrella, MET-Rx continues to focus on muscle recovery and metabolic support for high-performance athletes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Met-Rx.